177Lu-APOMAB

N/A

Report date: 2025/01/26 15:39:14

Base Information

Drug Name177Lu-APOMAB
Drug Alias Name177lutetium labeled chDAB4 antibody (Central Adelaide Local Health Network Inc)177lutetium labeled-APOMAB
ClassificationRadiation-emitting productsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTelix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTelix Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A